Stepping on BioMarin's turf, PTC Therapeutics picks up PKU drug for a song

While industry-shaking M&A deals are still nowhere in sight, smaller deals by bargain shoppers continue to trickle in. PTC Therapeutics has joined the club, bagging Censa Pharmaceuticals and its rare metabolic disease drug.